Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2015 Jul;144(1):59-66.
doi: 10.1007/s00418-015-1317-3. Epub 2015 Mar 19.

Neointimal hyperplasia in allogeneic and autologous venous grafts is not different in nature

Affiliations
Comparative Study

Neointimal hyperplasia in allogeneic and autologous venous grafts is not different in nature

Albert Busch et al. Histochem Cell Biol. 2015 Jul.

Abstract

Neointimal hyperplasia, transplant rejection and thus immunogenicity of allografts are possible reasons for poorer patency rates in cryopreserved venous allografts for peripheral bypass surgery in comparison with autologous venous grafts. To expand the limited knowledge from human allografts, we histologically investigated allogeneic and autologous venous grafts in arterial location. Specimens of allogeneic and autologous venous graft stenosis, harvested 6 months after bypass implantation, were immunohistochemically characterized. Examination of the lesions showed a uniform morphological pattern. A continuous endothelial layer, tissue fibrosis and a thickened neointima with monocytes and dedifferentiated vascular smooth muscle cells were seen in both conduits with very low cell turnover and the absence of acute and chronic inflammation. Neoangiogenesis with CD34-positive endothelium was abundant in the vessel media. The morphological patterns of allogeneic and autologous neointima formation are similar. Consequently, neointimal hyperplasia in venous grafts may reflect a uniform physiological host response of non-immunological factors with the reasons for poorer clinical outcome of cryopreserved allografts yet to be elucidated.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Transplant Proc. 2004 Dec;36(10):3288-94 - PubMed
    1. Curr Opin Pharmacol. 2012 Apr;12(2):114-20 - PubMed
    1. Expert Rev Cardiovasc Ther. 2012 May;10(5):635-47 - PubMed
    1. Eur J Vasc Endovasc Surg. 2011 Sep;42 Suppl 1:S19-29 - PubMed
    1. Circ J. 2010 Aug;74(8):1501-12 - PubMed

Publication types

LinkOut - more resources